BioCatalyst

Itepekimab (SAR440340), Mometasone furoate nasal spray (MFNS) — catalyst calendar

2 verified catalyst event(s) referencing Itepekimab (SAR440340), Mometasone furoate nasal spray (MFNS), each linked to its official source. Verified as of 2026-08-06.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-10-14
in 2mo
ESTIMATED
 READOUT
A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (
Phase 3 · Chronic Rhinosinusitis With Nasal Polyps
 SNY Sanofi Itepekimab (SAR440340), Mometasone furoa ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
2026-11-06
in 3mo
ESTIMATED
 READOUT
A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (
Phase 3 · Chronic Rhinosinusitis With Nasal Polyps
 SNY Sanofi Itepekimab (SAR440340), Mometasone furoa ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.